Evidence map›Paper›PMID 29987255›Full record

ArticleInternational journal of environmental research and public health2018

Prevalence of Vaccine Type Infections in Vaccinated and Non-Vaccinated Young Women: HPV-IMPACT, a Self-Sampling Study.

Emilien Jeannot, Manuella Viviano, Charlotte de Pree, Mona Amadane, Emmanuel Kabengele, Pierre Vassilakos, Patrick Petignat

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Emilien JeannotInstitute of Global Health-Faculty of Medicine, Chemin de Mines 9, 1202 Geneva, Switzerland. Emilien.jeannot@unige.ch.ORCID 0000-0002-6625-3575
Manuella VivianoGynecology Division, Department of Obstetrics and Gynecology, Geneva University Hospitals, Boulevard de la Cluse 30, 1205 Geneva, Switzerland. manuela.viviano@hcuge.ch.
Charlotte de PreeFaculty of Medicine, University of Geneva, 1205 Geneva, Switzerland. Charlotte.De-Pree@etu.unige.ch.
Mona AmadaneFaculty of Medicine, University of Geneva, 1205 Geneva, Switzerland. mona.amadane@etu.unige.ch.
Emmanuel KabengeleInstitute of Global Health-Faculty of Medicine, Chemin de Mines 9, 1202 Geneva, Switzerland. Emmanuel.Kabengele@unige.ch.
Pierre VassilakosGeneva Foundation for Medical Education and Research, Route de Ferney 150, 1211 Geneva 2, Switzerland. pierrevassilakos@bluewin.ch.
Patrick PetignatGynecology Division, Department of Obstetrics and Gynecology, Geneva University Hospitals, Boulevard de la Cluse 30, 1205 Geneva, Switzerland. patrick.petignat@hcuge.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

methodsUndergraduate women aged between 18⁻31 years, attending the Medical School and University of Applied Sciences in Geneva, were invited to participate in the study. Included women were asked to perform vaginal self-sampling for HPV testing using a dry cotton swab.

resultsA total of 409 students participated in the study-aged 18⁻31 years-of which 69% of the participants were vaccinated with Gardasil HPV vaccine and 31% did not received the vaccine. About HPV prevalence, 7.2% of unvaccinated women were HPV 16 or 18 positive, while 1.1% of vaccinated women were infected by HPV 16 or 18 (p < 0.01). Prevalence of HPV 6 and 11 was 8.3% in non-vaccinated women versus 2.1% in vaccinated women (p < 0.02). We observed no cross-protection for the other HPV genotypes of a low- and high-risk strain.

conclusionsPrevalence of HPV 6/11/16/18 was lower in vaccinated women versus unvaccinated women. Continued assessment of HPV vaccine effectiveness in real population is needed.

Indexed as

AdolescentAdultFemaleHuman papillomavirus 16Human papillomavirus 18HumansImmunizationPapillomavirus InfectionsPapillomavirus VaccinesPrevalenceSampling StudiesSwitzerlandVaccinationYoung AdultPapillomavirus VaccinesHPVself-samplingvaccination

Identifiers

PMID29987255
PMCPMC6069376

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.